Interaction and Functional Interplay Between Endoglin and ALK-1, Two Components of the Endothelial Transforming Growth Factor-beta Receptor Complex
Overview
Physiology
Authors
Affiliations
Transforming growth factor-beta (TGF-beta) signaling in endothelial cells is able to modulate angiogenesis and vascular remodeling, although the underlying molecular mechanisms remain poorly understood. Endoglin and ALK-1 are components of the TGF-beta receptor complex, predominantly expressed in endothelial cells, and mutations in either endoglin or ALK-1 genes are responsible for the vascular dysplasia known as hereditary hemorrhagic telangiectasia. Here we find that the extracellular and cytoplasmic domains of the auxiliary TGF-beta receptor endoglin interact with ALK-1 (a type I TGF-beta receptor). In addition, endoglin potentiates TGF-beta/ALK1 signaling, with the extracellular domain of endoglin contributing to this functional cooperation between endoglin and ALK-1. By contrast, endoglin appears to interfere with TGF-beta/ALK-5 signaling. These results suggest that the functional association of endoglin with ALK-1 is critical for the endothelial responses to TGF-beta.
ALK1 Signaling in Human Cardiac Progenitor Cells Promotes a Pro-angiogenic Secretome.
Moore M, Ryzhov S, Sawyer D, Gartner C, Vary C J Cell Signal. 2024; 5(3):122-142.
PMID: 39430425 PMC: 11488643. DOI: 10.33696/signaling.5.119.
Dimitry M, Soliman Y, Elkorashy R, Raslan H, Kamel S, Hassan E Egypt Heart J. 2023; 75(1):76.
PMID: 37646902 PMC: 10468479. DOI: 10.1186/s43044-023-00395-w.
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.
Welch C, Aldred M, Balachandar S, Dooijes D, Eichstaedt C, Graf S Genet Med. 2023; 25(11):100925.
PMID: 37422716 PMC: 10766870. DOI: 10.1016/j.gim.2023.100925.
Ruiz-Llorente L, Ruiz-Rodriguez M, Savini C, Gonzalez-Munoz T, Riveiro-Falkenbach E, Rodriguez-Peralto J Adv Exp Med Biol. 2023; 1408:253-272.
PMID: 37093432 DOI: 10.1007/978-3-031-26163-3_14.
Vaklavas C, Stringer-Reasor E, Elkhanany A, Ryan K, Li Y, Theuer C Breast Cancer Res Treat. 2023; 198(2):217-229.
PMID: 36735117 PMC: 10020303. DOI: 10.1007/s10549-023-06864-9.